FI901087A0 - Azolidindionderivat. - Google Patents

Azolidindionderivat.

Info

Publication number
FI901087A0
FI901087A0 FI901087A FI901087A FI901087A0 FI 901087 A0 FI901087 A0 FI 901087A0 FI 901087 A FI901087 A FI 901087A FI 901087 A FI901087 A FI 901087A FI 901087 A0 FI901087 A0 FI 901087A0
Authority
FI
Finland
Prior art keywords
azolidindionderivat
Prior art date
Application number
FI901087A
Other languages
English (en)
Finnish (fi)
Inventor
Steven W Goldstein
Reinhard Sarges
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI901087A0 publication Critical patent/FI901087A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FI901087A 1987-09-04 1990-03-02 Azolidindionderivat. FI901087A0 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1987/002196 WO1989001775A1 (fr) 1987-09-04 1987-09-04 Derives d'azolidinedione

Publications (1)

Publication Number Publication Date
FI901087A0 true FI901087A0 (fi) 1990-03-02

Family

ID=22202540

Family Applications (1)

Application Number Title Priority Date Filing Date
FI901087A FI901087A0 (fi) 1987-09-04 1990-03-02 Azolidindionderivat.

Country Status (21)

Country Link
EP (1) EP0306251A3 (fr)
JP (1) JPS6471882A (fr)
KR (1) KR900008841B1 (fr)
CN (1) CN1022325C (fr)
AU (1) AU595467B2 (fr)
CS (1) CS273186B2 (fr)
DD (1) DD273381A5 (fr)
DK (1) DK488688A (fr)
EG (1) EG18591A (fr)
FI (1) FI901087A0 (fr)
HU (1) HU204832B (fr)
IL (1) IL87590A (fr)
MX (1) MX12896A (fr)
MY (1) MY103765A (fr)
NO (1) NO901016L (fr)
PH (1) PH24957A (fr)
PL (1) PL156798B1 (fr)
PT (1) PT88407B (fr)
WO (1) WO1989001775A1 (fr)
YU (1) YU46863B (fr)
ZA (1) ZA886507B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5068333A (en) * 1990-03-07 1991-11-26 Pfizer Inc. 6-chloro-3,4-dihydro-pyrano [2,3-b]pyridines having the R configuration
DE10210195B4 (de) 2002-03-07 2005-12-15 Schwarz Pharma Ag Verwendung von 1,3-Diazaspiro-[4,5]decan-2,4-dithion zur Behandlung von Schmerz
DK1873145T3 (da) * 2005-04-21 2012-10-29 Ishihara Sangyo Kaisha Fremgangsmåde til fremstilling af nikotinsyrederivat eller salt deraf

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1088945A (fr) * 1976-10-18 1980-11-04 Pfizer Limited Derives de l'hydantoine utilises comme agents therapeutiques
US4176185A (en) * 1979-01-22 1979-11-27 Pfizer Inc. Spiro-quinolylhydantoins
US4226875A (en) * 1979-04-02 1980-10-07 Pfizer Inc. Novel spiro-oxazolidinediones
FR2455046A1 (fr) * 1979-04-25 1980-11-21 Science Union & Cie Nouvelles hydantoines, leur procede de preparation et leur emploi comme medicament
US4235911A (en) * 1979-06-13 1980-11-25 Pfizer Inc. Hydantoin derivatives
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
ATE11781T1 (de) * 1981-05-13 1985-02-15 Imperial Chemical Industries Plc Pharmazeutische zubereitungen, die spirosuccinimidderivate enthalten.

Also Published As

Publication number Publication date
WO1989001775A1 (fr) 1989-03-09
IL87590A0 (en) 1989-01-31
EP0306251A2 (fr) 1989-03-08
NO901016L (no) 1990-05-02
YU46863B (sh) 1994-06-24
KR900008841B1 (ko) 1990-11-30
EG18591A (en) 1993-06-30
PT88407A (pt) 1989-07-31
CN1031702A (zh) 1989-03-15
KR890005112A (ko) 1989-05-11
PT88407B (pt) 1992-10-30
MX12896A (es) 1993-06-01
ZA886507B (en) 1990-04-25
MY103765A (en) 1993-09-30
CN1022325C (zh) 1993-10-06
YU167788A (en) 1990-06-30
CS591188A2 (en) 1990-06-13
PL274504A1 (en) 1989-05-02
DK488688D0 (da) 1988-09-02
JPH0583554B2 (fr) 1993-11-26
HUT56106A (en) 1991-07-29
JPS6471882A (en) 1989-03-16
DD273381A5 (de) 1989-11-15
NO901016D0 (no) 1990-03-02
AU595467B2 (en) 1990-03-29
AU2184188A (en) 1989-03-09
EP0306251A3 (fr) 1990-08-01
PL156798B1 (pl) 1992-04-30
HU204832B (en) 1992-02-28
CS273186B2 (en) 1991-03-12
DK488688A (da) 1989-04-07
IL87590A (en) 1992-07-15
PH24957A (en) 1990-12-26

Similar Documents

Publication Publication Date Title
DE3880632D1 (de) Kuevette.
DE3881291D1 (de) Sehapparat.
DE3862564D1 (de) Erdanker.
FI77952B (fi) Ljusbaogsrelae.
DE3867976D1 (de) Polymergebundene antioxydationsmittel.
DE3883705D1 (de) Alkenylbicyclohexane.
DE3876873D1 (de) Weblitzenuebergabevorrichtung.
DE3785663D1 (de) Loetgeraet.
DE3876304D1 (de) Polysilacylobutasilazane.
DE3882446D1 (de) Polydisilacyclobutasilazane.
DE3870513D1 (de) Tennisball.
DE3888991D1 (de) Aminokohlenwasserstoff-substituierte Ketoximosilane.
DE3879348D1 (de) Fm-cw-radargeraet.
FI77055B (fi) Vaermegradient-inkubator.
DE3877421D1 (de) Polyamidbenzazole.
DE3862309D1 (de) Aminomethyltetrahydrofurane.
DE3878970D1 (de) Praeparative chromatographiesaeule.
FI86994B (fi) Korrosionsfasta vismut innehaollande zirkoniumlegeringar.
DE3861694D1 (de) Cyclopropancarboxamide.
DE3860307D1 (de) 2-aminomethyltetrahydrofurane.
DE3860710D1 (de) Exklusiv-oder-schaltung.
DE3866770D1 (de) Gerbstoff.
DE3867805D1 (de) Paraocclusaler loeffel.
DE3873615D1 (de) Polycyanoarylthioether.
DE3879625D1 (de) Laseroszillator.

Legal Events

Date Code Title Description
FD Application lapsed
MM Patent lapsed

Owner name: PFIZER INC.